Goldman Sachs Starts Qiagen NV (QGEN) at Sell, Sees 12% Downside
Tweet Send to a Friend
Goldman Sachs initiates coverage on Qiagen NV (NASDAQ: QGEN) with a Sell rating and $18 price target ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


